Company Profile

Surrozen Stock Price, News & Catalysts

Ticker:
SRZN
Exchange:
NASDAQ
Sector:
Biopharma
Location:
United States

Stock performance

23.99 USD (+2.09%)

Close

Last updated: August 21, 2026

269M USD

Market cap

Why the stock is moving

As of Aug 21, 2026, SRZN closed up 2.09% at $23.99. No new same-company headline was identified in the current news window.

Company overview

Business overview

Surrozen is a biotechnology company focused on tissue regeneration and organ repair through Wnt biology. Its story centers on whether developmental biology can be translated into therapies for difficult diseases.

Geographic Base and Sector Classification

Surrozen is headquartered in the United States and listed on NASDAQ. It sits in the regenerative and platform-biotech segment.

Business Model Characteristics

The company depends on translational science, platform validation, and the ability to keep a narrow pipeline funded while it develops its biology. Investors watch early data, strategic changes, and financing needs.

Position Within the Biotechnology Landscape

Surrozen occupies a specialized regenerative-biology niche within biotech. The stock is sensitive to whether its platform can move beyond concept toward clinical relevance.

Future catalysts

  • Surrozen’s catalysts are Wnt-biology programs and any update that shows the regenerative-medicine platform can still advance. The company is still early and data-dependent.

Recent news

    Similar stocks

    Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.

    Frequently Asked Questions

    What is the current stock price of Surrozen (SRZN)?

    Surrozen (SRZN) most recently closed at 23.99 USD, a +2.09% move versus the previous session.

    What is the market cap of Surrozen (SRZN)?

    Surrozen currently has a market capitalization of 269M USD on BioPharmSignal.

    What does Surrozen do?

    Surrozen is a biotechnology company focused on tissue regeneration and organ repair through Wnt biology. Its story centers on whether developmental biology can be translated into therapies for difficult diseases.

    On which exchange is SRZN stock listed?

    Surrozen (SRZN) is associated with NASDAQ, United States, Biopharma.

    What is Surrozen?

    Surrozen’s catalysts are Wnt-biology programs and any update that shows the regenerative-medicine platform can still advance.

    Which conditions is Surrozen targeting with Surrozen?

    Surrozen’s catalysts are Wnt-biology programs and any update that shows the regenerative-medicine platform can still advance.

    How does Surrozen describe recent progress with Surrozen?

    Surrozen’s catalysts are Wnt-biology programs and any update that shows the regenerative-medicine platform can still advance.

    What is Wnt-biology?

    Surrozen’s catalysts are Wnt-biology programs and any update that shows the regenerative-medicine platform can still advance.